Third-line chemotherapy with CCNU, etoposide and prednimustine (CEP) in Hodgkin's disease (HD) resistant to MOPP and ABVD

A. Santoro, V. Bonfante, G. Bonadonna

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationProceedings of the American Society of Clinical Oncology
VolumeVol. 1
Publication statusPublished - 1982

ASJC Scopus subject areas

  • Medicine(all)

Cite this